New England Journal of Medicine· 2012Q1
Aspirin for Preventing the Recurrence of Venous Thromboembolism
- 620citations
- Q1SCImago
- 2012year
Short summary
Aspirin (100 mg daily) reduced the risk of recurrent venous thromboembolism (VTE) by 45% compared to placebo in patients who had completed anticoagulant therapy, with no significant increase in major bleeding.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine